Immunome (IMNM) Return on Sales (2023 - 2026)

Immunome's (IMNM) quarterly Return on Sales came in at 1.22% in Q1 2026, down 107.0% YoY from 17.41% in Q1 2025, and down 191.72% on a QoQ basis from 0.42% in Q4 2025.

Immunome (IMNM) Return on Sales (2023 - 2026) Analysis & Trends

Immunome (IMNM) has 4 years of Return on Sales data on file, last reported at 1.22% in Q1 2026.

  • Quarterly Return on Sales fell 107.0% year-over-year to 1.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.22% (down 92.0% YoY) and the FY2025 annual result came in at 0.58%, down 13.0% from the prior year.
  • Return on Sales declined to 1.22% in Q1 2026, from 0.42% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q1 2023 to a low of 1.29% in Q1 2024.
  • A 4-year average of 0.38% and a median of 0.3% in 2024 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2024 — Return on Sales plunged 127 bps — and 2025, when it surged 113 bps.
  • Tracing IMNM's Return on Sales over 4 years: stood at 0.25% in 2023, then retreated by 23 bps to 0.3% in 2024, then plunged by 37 bps to 0.42% in 2025, then plunged by 192 bps to 1.22% in 2026.
  • The last three Return on Sales figures came in at 1.22% (Q1 2026), 0.42% (Q4 2025), and 0.31% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Immunome 3.09 Bn 2.57 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.22%
Dec 31, 2025 -0.42%
Sep 30, 2025 -0.31%
Jun 30, 2025 -0.18%
Mar 31, 2025 -0.15%
Dec 31, 2024 -0.30%
Sep 30, 2024 -0.40%
Jun 30, 2024 -0.36%
Mar 31, 2024 -1.29%
Dec 31, 2023 -0.25%
Sep 30, 2023 -0.04%
Jun 30, 2023 -0.04%
Mar 31, 2023 -0.02%